Showing 3941-3950 of 9152 results for "".
- New Research Explores Nanotechnology as a Vehicle for Delivering Cannabinoids in Dermatologyhttps://practicaldermatology.com/news/new-research-explores-nanotechnology-as-a-vehicle-for-delivering-cannabinoids-in-dermatology/2460849/Nanotechnology delivery systems may be an innovative and effective approach to delivering cannabinoids for skin care, according to a team from the Department of Dermatology at the George Washington University School of Medicine and Health Sciences in Washington, DC. Research fellow Naga
- OMNY Health Launches Integrated Dermatology Data Repository and Research Networkhttps://practicaldermatology.com/news/omny-health-launches-integrated-dermatology-data-repository-and-research-network/2460845/OMNY Health has partnered with community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research. The assembled longitudinal data represents care delivered over the pas
- Nutrafol Launches Postpartum Formulahttps://practicaldermatology.com/news/nutrafol-launches-postpartum-formula/2460838/The first-of-its-kind postpartum hair nutraceutical is now available from Nutrafol. Nutrafol Postpartum was developed with an OB/GYN to target the root causes of excess hair shedding and thinning post-pregnancy. It is intended to help the body recover from the physical stress of childbirth,
- AAD Survey: Only a Third of Americans are Concerned about Skin Cancer Despite Nearly 70% Having at Least One Risk Factorhttps://practicaldermatology.com/news/aad-survey-only-a-third-of-americans-are-concerned-about-skin-cancer-despite-nearly-70-having-at-least-one-risk-factor/2460836/Despite skin cancer being the most common cancer in the U.S., only about one-third of adults are concerned about developing the disease, even though nearly 70 percent say they have at least one risk factor for skin cancer, according to a new American Academy of Dermatology (AAD) survey.
- Dermatologist Named as AMA President-Electhttps://practicaldermatology.com/news/dermatologist-named-as-ama-president-elect/2460835/Jack Resneck Jr, MD, a dermatologist from the San Francisco Bay Area, is the new president-elect of the American Medical Association (AMA). Following a year-long term as president-elect, Dr. Resneck will assume the office of AMA president in June 2022. “It is truly an honor t
- Nurx Adds Rosacea Care to List of Serviceshttps://practicaldermatology.com/news/nurx-adds-rosacea-care-to-list-of-services/2460832/Nurx, now includes rosacea treatment in its at-home dermatology services. The service consists of a consultation with a Nurx medical provider, a personalized treatment plan for rosacea, home delivery of medication, and ongoing care. The expansion builds on the successful launch of Nurx&
- Merz Aesthetics Launches New Online Aesthetics Education Platformhttps://practicaldermatology.com/news/merz-aesthetics-launches-new-online-aesthetics-education-platform/2460830/Merz Aesthetics is launching Merz Aesthetics Medical Forum, an online medical aesthetics education platform for health care professionals around the world. Established by Merz Aesthetics Global Medical Affairs, the Medical Forum provides on-demand content focused on medical aesthe
- New Research Shows How Immune Cells Organize Themselves in the Epidermishttps://practicaldermatology.com/news/new-research-shows-how-immune-cells-organize-themselves-in-the-epidermis/2460827/New research reveals how the skin’s immune cells organize themselves to ward off would-be intruders. Skin’s immune cells have a history of being misunderstood. Many people don’t realize that the epidermis is home to immune cells. To bring more cla
- SkinSAFE, CVS Name Top 25 2021 Sunscreen Award Winners for Sensitive Skinhttps://practicaldermatology.com/news/skinsafe-cvs-name-top-25-2021-sunscreen-award-winners-for-sensitive-skin/2460826/SkinSAFE partnered with CVS Pharmacy, through the retailer's "Sensitive-Friendly" program, for the first-ever awards that recognize popular products that are safe for sensitive skin types. The experts at
- Dermavant Submits NDA for Tapinarof for PsOhttps://practicaldermatology.com/news/dermavant-submits-nda-for-tapinarof-for-pso/2460820/Dermavant Sciences has submitted a New Drug Application (NDA) to the FDA for tapinarof for the treatment of mild, moderate, and severe plaque psoriasis in adult patients. Tapinarof is a novel, therapeutic aryl hydrocarbon receptor modulating agent, in development as a once-daily,